ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $41,197,000 | -32.4% | 1,019,236 | -3.8% | 0.02% | -26.7% |
| Q2 2015 | $60,979,000 | +0.3% | 1,059,580 | +10.9% | 0.03% | 0.0% |
| Q1 2015 | $60,818,000 | +11.9% | 955,196 | +8.5% | 0.03% | +7.1% |
| Q4 2014 | $54,351,000 | +86.1% | 880,326 | +17.1% | 0.03% | +75.0% |
| Q3 2014 | $29,203,000 | -43.6% | 752,077 | -50.0% | 0.02% | +14.3% |
| Q2 2014 | $51,818,000 | +59.5% | 1,504,154 | +100.0% | 0.01% | -22.2% |
| Q1 2014 | $32,497,000 | +8.5% | 752,077 | 0.0% | 0.02% | +5.9% |
| Q4 2013 | $29,962,000 | +9.9% | 752,077 | +3.5% | 0.02% | +6.2% |
| Q3 2013 | $27,273,000 | +110.0% | 726,482 | +50.3% | 0.02% | +100.0% |
| Q2 2013 | $12,987,000 | +36.4% | 483,296 | -14.0% | 0.01% | +33.3% |
| Q1 2013 | $9,520,000 | +76.4% | 562,014 | +46.5% | 0.01% | +50.0% |
| Q3 2012 | $5,397,000 | +16.1% | 383,610 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $4,649,000 | – | 383,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|